CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript October 30, 2024
CorMedix Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1.
Operator: Good day and welcome to the CorMedix Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I’d now like to turn the conference over to Dan Ferry of LifeSci Advisors. Please go ahead.
Dan Ferry: Thanks, operator. Good morning and welcome to the...
